Varithena injectable foam 45ML
Ended Awarded
- Contract number
- SPE2DB25FYX23
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,553
Award facts
- Contract value 100% obligated
- $19,553.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,553.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 45 milliliters of Varithena injectable foam. The delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, carries no set-aside designation. This award represents a single delivery order executed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
Varithena is a prescription injectable foam medication used for the treatment of varicose veins and venous insufficiency. DMS Pharmaceutical Group's role as the prime contractor involves the direct distribution and delivery of this specialized pharmaceutical product to support medical supply needs across military health facilities. The company's established federal procurement portfolio demonstrates consistent success in supplying branded and generic prescription drugs, biologics, and medical consumables to defense healthcare systems, positioning it as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DB25FYX23?
SPE2DB25FYX23 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FYX23 worth?
The government has obligated $19,553 on SPE2DB25FYX23.
Is contract SPE2DB25FYX23 an order under another contract?
Yes. SPE2DB25FYX23 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX23 competed?
The extent of competition for SPE2DB25FYX23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award